Judge Cuts 2nd Cymbalta Trial Short With Verdict For Lilly

Law360, New York (August 13, 2015, 2:39 PM EDT) -- Eli Lilly & Co. on Thursday defeated claims that it concealed the withdrawal risks of its antidepressant Cymbalta when a California federal judge cut short a trial and issued a directed verdict for the drugmaker, less than a week after jurors in another California suit cleared the company.

U.S. District Judge Stephen V. Wilson issued a directed verdict Thursday ending the trial, following the close of plaintiff Erin Hexum's case-in-chief late Wednesday, according to a court transcript. Judge Wilson on Thursday morning told the parties he...
To view the full article, register now.



Case Information

Case Title

Erin Hexum et al v. Eli Lilly and Company et al

Case Number



California Central

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability


Stephen V. Wilson

Date Filed

April 17, 2013

Law Firms


Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.